2,7-Diamino-6-phenylpteridin-4-ol

Catalog No. :
ACJRRB261
CAS No. :
19375-89-4
Molecular Formula :
C12H10N6O
Molecular Weight :
254.25

IUPAC Name:2,7-diamino-6-phenylpteridin-4(3H)-one

2,7-Diamino-6-phenylpteridin-4-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$441.00Login to see priceInquiryInquiry
250mg95%$736.00Login to see priceInquiryInquiry
1g95%$1472.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,7-Diamino-6-phenylpteridin-4-ol
IUPAC Name2,7-diamino-6-phenylpteridin-4(3H)-one
Molecular FormulaC12H10N6O
Molecular Weight254.25
SMILESOC1=C2N=C(C3=CC=CC=C3)C(N)=NC2=NC(N)=N1
InChI KeyUDZYJMZMGMKNJZ-UHFFFAOYSA-N
Synonym2,7-DiaMino-6-phenyl-4-pteridinol;TriaMterene Related CoMpound B;2,7-Diamino-4-hydroxy-6-phenylpteridine;2,7-Diamino-6-phenylpteridin-4-ol;Triamterene Related Compound B (50 mg) (2,7-diamino-4-hydroxy-6-phenylpteridine);2,7-diamino-6-phenyl-1H-pteridin-4-one;Triamterene EP Impurity B;2,7-Diamino-4-hydroxy-6-phenylpteridine, 2,7-Diamino-6-phenylpteridin-4-ol
CAS No.19375-89-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACJRRB261 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJRRB261 route product structure diagram
    ACJRRB26119375-89-4
Inquiry

2. ACJRRB261 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACJRRB261 route product structure diagram
    ACJRRB26119375-89-4
Inquiry

Comments (0)